Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Study identifies weight-loss drug target in the brain

A team led by researchers from UT Southwestern Medical Center and a university in South Korea has identified a subset of brain cells whose activation may be partially responsible for the effects of a popular class of weight loss drugs that includes semaglutide and tirzepatide. Their findings, published in Science, could eventually help scientists optimize the efficacy of these drugs, known as glucagon-like peptide-1 receptor agonists (GLP-1RAs).

August 8, 2024


July 11 2025

July 10 2025

July 9 2025

July 8 2025

July 7 2025

July 6 2025

July 5 2025

July 4 2025

July 3 2025

July 2 2025

July 1 2025

June 30 2025

June 29 2025

June 28 2025

June 27 2025